Th17 and regulatory T cells in patients with different time of progression of type 2 diabetes mellitus
Central European Journal of Immunology · 06.04.2020 · 45 (1) · 29-36
DOI: 10.5114/ceji.2020.94670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Central European Journal of Immunology, online erschienen am 06.04.2020. Verfasst von Juan Manuel Guzmán-Flores und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Campus León, University of Guanajuato, León, Guanajuato, México. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
The aim of this study was to determine the relationship between Treg and Th17 in patients with different times of type 2 diabetes mellitus (T2DM) progression. Material and methods: Nineteen control subjects and 40 patients with T2DM were included. T2DM patients were classified into two groups; twenty patients had less than 10 years of disease progression (T2DM10). Additionally, an analysis was performed according to the metabolic control, depending on HbA1c levels. The peripheral blood ratio of both Th17 and Treg cells was measured by standard flow cytometry protocols. Results: No significant difference was found in Th17 cells of patients with T2DM 10 and controls. With respect to CD4+ CD25+ FoxP3+ and CD4+ CD25h Treg cells, a significant decrease was observed in patients with T2DM>10, mainly in patients with poor or moderate metabolic control. When statistical analysis was performed on all patients with T2DM as a group, a decrease on three cell subsets was observed; as well a negative correlation between Th17 cells and total cholesterol, CD4+ CD25h cells with glucose and HbA1c levels; while a positive correlation was observed between CD4+ CD25h cells and BMI. Conclusions: here was shown a decrease on both Treg and Th17 cell subsets in T2DM patients; suggesting that the metabolic decontrol and the progression time of T2DM could modify the proportions of the Th17 and T Reg cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Sciences, Campus León, University of Guanajuato, León, Guanajuato, México.
- Department of Clinics, Los Altos University Center, University of Guadalajara, Tepatitlán de Morelos, Jalisco, Mexico.
- Department of Medicine and Nutrition, Division of Health Sciences, Campus León, University of Guanajuato, Guanajuato, México.
Zitieren
APA
Guzmán-Flores, J. M., Ramírez-Emiliano, J., Pérez-Vázquez, V., & López-Briones, S. (2020). Th17 and regulatory T cells in patients with different time of progression of type 2 diabetes mellitus. Central European Journal of Immunology, 45(1), 29-36. https://doi.org/10.5114/ceji.2020.94670
Vancouver
Guzmán-Flores JM, Ramírez-Emiliano J, Pérez-Vázquez V, López-Briones S. Th17 and regulatory T cells in patients with different time of progression of type 2 diabetes mellitus. Central European Journal of Immunology. 2020;45(1):29-36. doi:10.5114/ceji.2020.94670
BibTeX
@article{GuzmnFlores2020,
author = {Guzmán-Flores, Juan Manuel and Ramírez-Emiliano, Joel and Pérez-Vázquez, Victoriano and López-Briones, Sergio},
title = {Th17 and regulatory T cells in patients with different time of progression of type 2 diabetes mellitus},
journal = {Central European Journal of Immunology},
year = {2020},
volume = {45},
number = {1},
pages = {29--36},
doi = {10.5114/ceji.2020.94670}
}
EUVIMED